as on September 9, 2025 at 1:29 am IST
Day's Low
Day's High
10.90%
Downside
1.66%
Upside
52 Week's Low
52 Week's High
72.27%
Downside
216.63%
Upside
Check Bioxcel Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$55.2M
EPS (TTM)
-5.43
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-0.24
Industry PE ratio
-197.17
P/B Ratio
0PEG Ratio
0EBITDA
-49.8M
Revenue (TTM)
868.0K
Profit Margin
0.00%
Return On Equity TTM
1337600.00%
Track how Bioxcel Therapeutics P/E has moved over time to understand its valuation trends.
Bioxcel Therapeutics in the last 5 years
Lowest (0.00x)
September 8, 2025
Industry (-197.17x)
September 8, 2025
Today (-0.24x)
September 8, 2025
Highest (-0.67x)
March 31, 2025
Today’s Price to Earnings Ratio: -0.24x
Compare market cap, revenue, PE, and other key metrics of Bioxcel Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $55.2M | -99.44% | -0.24 | 0.00% | |
NA | $39.2B | NA | NA | -3.89% | |
BUY | $59.2B | 267.51% | -505.15 | -12.96% | |
BUY | $101.6B | 53.17% | 28.17 | 31.86% | |
BUY | $60.8B | 2.04% | 14.45 | 31.37% |
The Bioxcel Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Bioxcel Therapeutics investment value today
Current value as on today
₹53,070
Returns
Returns from Bioxcel Therapeutics Stock
Dollar Returns*
₹4,786 (+4.79%)
Based on 13 analysts
69.23%
Buy
30.77%
Hold
0.00%
Sell
Based on 13 analysts, 69.23% of analysts recommend a 'BUY' rating for Bioxcel Therapeutics. Average target price of $19.4
Get share price movements and forecasts by analysts on Bioxcel Therapeutics.
What analysts predicted
78.25%UPSIDE
Target Price
$19.4
Current Price
$4.22
Analyzed by
13 Analysts
Target
$19.40
Bioxcel Therapeutics target price $19.4, a slight upside of 78.25% compared to current price of $4.22. According to 13 analysts rating.
Investment in Bioxcel Therapeutics Shares on INDmoney has grown by 64.70% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:64.70% versus previous 30 day period
Search interest for Bioxcel Therapeutics Stock has increased by 119% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:119% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 3 months, BTAI stock has moved up by 106.0%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 83.2% return, outperforming this stock by 139.8%
Against Peers
In the last 3 years, Beone Medicines Ltd has given 99.7% return, outperforming this stock by 198.1%
Revenue Fall
Revenue is down for the last 3 quarters, 366.0K → 120.0K (in $), with an average decrease of 41.3% per quarter
Profit Down
Netprofit is down for the last 2 quarters, -7.25M → -19.18M (in $), with an average decrease of 164.5% per quarter
Organisation | Bioxcel Therapeutics |
Headquarters | 555 Long Wharf Drive, New Haven, CT, United States, 06511 |
Industry | Health Technology |
CEO | Dr. Vimal D. Mehta Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. Vimal D. Mehta Ph.D. | Founder, CEO, President, & Director |
Mr. Richard I. Steinhart MBA | Senior VP & CFO |
Mr. Javier Rodriguez J.D. | Senior VP, Chief Legal Officer & Corporate Secretary |
Dr. Frank D. Yocca Ph.D. | Executive VP & Chief Scientific Officer |
Bioxcel Therapeutics share price today is $4.22 as on at the close of the market. Bioxcel Therapeutics share today touched a day high of $4.29 and a low of $3.76.
Bioxcel Therapeutics share touched a 52 week high of $13.36 on and a 52 week low of $1.17 on . Bioxcel Therapeutics stock price today i.e. is closed at $4.22,which is 68.42% down from its 52 week high and 260.68% up from its 52 week low.
Bioxcel Therapeutics market capitalisation is $0.00T as on .
Indian investors can start investing in Bioxcel Therapeutics (BTAI) shares with as little as ₹88.008 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.08 in Bioxcel Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Bioxcel Therapeutics share’s latest price of $4.22 as on September 9, 2025 at 1:29 am IST, you will get 2.3697 shares of Bioxcel Therapeutics. Learn more about
fractional shares .
Bioxcel Therapeutics stock has given -99.44% share price returns and 19.81% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?